A carregar...
Blockade of TRPV2 is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy
Muscular dystrophy and dilated cardiomyopathy are intractable diseases and their treatment options are very limited. Transient receptor potential cation channel subfamily V, member 2 (TRPV2), is a stretch-sensitive Ca(2+)-permeable channel that causes sustained intracellular Ca(2+) increase in muscu...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6720432/ https://ncbi.nlm.nih.gov/pubmed/31394715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20163844 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|